Founded in Pompano Beach, United States, Stimwave Technologies develops wireless microsize injectable devices aimed at providing innovative neurology solutions. The company's core mission is to revolutionize pain management and neurological treatments through minimally invasive technology. Their primary products include wireless neurostimulators designed to offer effective pain relief without the need for extensive surgical procedures. Stimwave primarily serves the U.S. market, focusing on enhancing patient outcomes in the neurology sector.

Notable affiliated individuals include the company's founders and key medical advisors who have contributed to its technological advancements. Despite filing for Chapter 11 bankruptcy protection in June 2022, Stimwave's assets were acquired by Curonix LLC in October 2022, ensuring the continuation of its pioneering work. Stimwave's impact lies in its innovative approach to pain management, offering patients less invasive alternatives to traditional treatments.